: Abbott, FDA reach deal to resume making baby formula at U.S. plant amid shortage

Abbott Laboratories and the Food and Drug Administration reached a deal Monday to restart production of baby formula at a U.S. plant that has been shut down amid a recall of the product, which contributed to a nationwide shortage of formula.

Previous post The Ratings Game: SoFi shares have taken too heavy a beating ahead of ‘significant earnings momentum,’ analyst says
Next post Best New Ideas in Retirement: ‘This is a daunting time to retire’: In the age of inflation, there are steps you can take to deal with higher prices